SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-14-192459
Filing Date
2014-05-09
Accepted
2014-05-09 16:10:59
Documents
7
Effectiveness Date
2014-05-09

Document Format Files

Seq Description Document Type Size
1 DEFA14A d697779ddefa14a.htm DEFA14A 53772
2 GRAPHIC g697779notice_p1001.jpg GRAPHIC 6913
3 GRAPHIC g697779notice_p1002.jpg GRAPHIC 1538
4 GRAPHIC g697779notice_p2001.jpg GRAPHIC 3133
5 GRAPHIC g697779notice_p2002.jpg GRAPHIC 1542
6 GRAPHIC g697779notice_p3001.jpg GRAPHIC 1402
7 GRAPHIC g697779notice_p4001.jpg GRAPHIC 1415
  Complete submission text file 0001193125-14-192459.txt   77693
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36172 | Film No.: 14829221
SIC: 2836 Biological Products, (No Diagnostic Substances)